BioAtla reported revenue of $6.50M and net income of $0.45M for the quarter ended Jun 2026. This income statement covers 26 quarters of results from Mar 2020 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Income Statement | Mar2020 | Jun2020 | Sep2020 | Dec2020 | Mar2021 | Jun2021 | Sep2021 | Dec2021 | Mar2022 | Jun2022 | Sep2022 | Dec2022 | Mar2023 | Jun2023 | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Mar2026 | Jun2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Shares Outstanding (Entity)Shares Outstanding (Entity.) | 35.19M | 35.80M | 35.89M | 35.99M | 36.37M | 46.34M | 47.64M | 47.80M | 47.91M | 48.08M | 48.11M | 48.33M | 48.35M | 58.10M | 58.40M | 58.72M | 58.79M | 63.46M | 1.66M | 1.66M | ||||||
| Revenue & cost | ||||||||||||||||||||||||||
| Revenue | 11.00M | 2.00M | 6.50M | |||||||||||||||||||||||
| Operating items | ||||||||||||||||||||||||||
| Research & DevelopmentR&D | 16.55M | 16.45M | 16.92M | 20.71M | 19.84M | 21.87M | 21.70M | 30.96M | 28.40M | 22.67M | 18.85M | 16.20M | 16.39M | 11.65M | 12.36M | 13.68M | 9.54M | 8.00M | 4.58M | 3.34M | ||||||
| Selling, General & AdministrativeSG&A | 7.14M | 7.04M | 7.42M | 8.34M | 6.34M | 6.69M | 7.23M | 6.24M | 6.62M | 5.86M | 5.61M | 5.77M | 5.88M | 4.59M | 5.26M | 4.96M | 4.25M | 3.26M | 4.73M | 2.93M | ||||||
| Other Operating ExpensesOther Opex | ||||||||||||||||||||||||||
| Operating ExpensesOpex | 23.70M | 23.49M | 24.35M | 29.05M | 26.18M | 28.56M | 28.93M | 37.20M | 35.02M | 28.54M | 24.46M | 21.97M | 22.27M | 16.24M | 17.61M | 18.65M | 13.79M | 11.26M | 9.31M | 6.27M | ||||||
| Operating IncomeOp. Inc | -23.70M | -23.49M | -24.35M | -29.05M | -26.18M | -28.56M | -28.93M | -37.20M | -35.02M | -28.54M | -24.46M | -21.97M | -11.27M | -16.24M | -17.61M | -18.65M | -13.79M | -9.26M | -9.31M | 0.23M | ||||||
| EBIT | -23.70M | -23.49M | -24.35M | -29.05M | -26.18M | -28.56M | -28.93M | -37.20M | -35.02M | -28.54M | -24.46M | -21.97M | -11.27M | -16.24M | -17.61M | -18.65M | -13.79M | -9.26M | -9.31M | 0.23M | ||||||
| Non-operating items | ||||||||||||||||||||||||||
| Non Operating Interest Expenses | 0.01M | 0.00M | 0.02M | 0.01M | ||||||||||||||||||||||
| Interest & Investment IncomeInt & Inv Inc | 0.08M | 0.10M | 0.09M | 0.15M | 0.37M | 1.05M | 1.48M | 1.46M | 1.73M | 1.64M | 1.22M | 0.90M | 0.69M | 0.55M | 0.40M | 0.23M | 0.13M | 0.07M | 0.04M | 0.02M | ||||||
| Other Non Operating IncomeOther Non Op Inc. | 0.77M | 0.10M | 0.09M | 0.15M | 0.40M | 1.02M | 1.47M | 1.45M | 1.70M | 1.61M | 1.22M | 0.90M | 0.68M | 1.36M | 2.28M | -0.06M | -1.99M | -0.53M | 2.96M | 0.23M | ||||||
| Non Operating IncomeNon Op. Inc. | -0.00M | 0.00M | 0.01M | 0.00M | 0.03M | -0.03M | -0.01M | -0.01M | -0.04M | -0.03M | -0.01M | -0.00M | ||||||||||||||
| Net income details | ||||||||||||||||||||||||||
| EBT | -23.62M | -23.39M | -24.26M | -28.91M | -25.81M | -27.51M | -27.45M | -35.74M | -33.29M | -26.90M | -23.23M | -21.07M | -10.59M | -15.69M | -17.21M | -18.41M | -13.66M | -9.18M | -9.29M | 0.23M | ||||||
| Profit After TaxPAT | -22.93M | -23.39M | -24.25M | -28.91M | -25.78M | -27.54M | -27.46M | -35.75M | -33.33M | -26.93M | -23.23M | -21.07M | -10.59M | -14.88M | -15.33M | -18.71M | -15.78M | -9.78M | -6.34M | 0.45M | ||||||
| Income from Continuing OperationsIncome (Continuing) | -23.62M | -23.39M | -24.26M | -28.91M | -25.81M | -27.51M | -27.45M | -35.74M | -33.29M | -26.90M | -23.23M | -21.07M | -10.59M | -15.69M | -17.21M | -18.41M | -13.66M | -9.18M | -9.29M | 0.23M | ||||||
| Consolidated Net IncomeConsol Net Inc. | -23.62M | -23.39M | -24.26M | -28.91M | -25.81M | -27.51M | -27.45M | -35.74M | -33.29M | -26.90M | -23.23M | -21.07M | -10.59M | -15.69M | -17.21M | -18.41M | -13.66M | -9.18M | -9.29M | 0.23M | ||||||
| Income towards Parent CompanyParent Net Inc | -23.62M | -23.39M | -24.26M | -28.91M | -25.81M | -27.51M | -27.45M | -35.74M | -33.29M | -26.90M | -23.23M | -21.07M | -10.59M | -15.69M | -17.21M | -18.41M | -13.66M | -9.18M | -9.29M | 0.23M | ||||||
| Net Income towards Common StockholdersNet Income | -22.93M | -23.39M | -24.26M | -28.91M | -25.81M | -27.51M | -27.45M | -35.74M | -33.29M | -26.90M | -23.23M | -21.07M | -10.59M | -15.69M | -17.21M | -18.41M | -13.66M | -9.18M | -9.29M | 0.23M | ||||||
| Additional items | ||||||||||||||||||||||||||
| EPS (Basic) | -0.68 | -0.68 | -0.65 | -0.77 | -0.69 | -0.71 | -0.58 | -0.75 | -0.70 | -0.56 | -0.48 | -0.44 | -0.22 | -0.32 | -0.30 | -0.31 | -0.23 | -0.16 | -6.19 | 0.14 | ||||||
| EPS (Diluted) | -0.68 | -0.68 | -0.65 | -0.77 | -0.69 | -0.71 | -0.58 | -0.75 | -0.70 | -0.56 | -0.48 | -0.44 | -0.22 | -0.32 | -0.30 | -0.31 | -0.23 | -0.16 | -6.19 | 0.14 | ||||||
| Shares Outstanding | 33.91M | 34.56M | 37.32M | 37.42M | 37.52M | 38.93M | 47.58M | 47.71M | 47.83M | 47.78M | 48.09M | 48.21M | 48.34M | 48.57M | 58.25M | 58.50M | 58.75M | 58.83M | 1.50M | 1.66M | ||||||
| Shares Outstanding (Diluted)Shares Outstanding (Dil.) | 33.91M | 34.56M | 37.32M | 37.42M | 37.52M | 38.93M | 47.58M | 47.71M | 47.83M | 47.78M | 48.09M | 48.21M | 48.34M | 48.57M | 58.25M | 58.50M | 58.75M | 58.83M | 1.50M | 1.66M | ||||||
| EBITDA | -23.70M | -23.49M | -24.35M | -29.05M | -26.18M | -28.56M | -28.93M | -37.20M | -35.02M | -28.54M | -24.46M | -21.97M | -11.27M | -16.24M | -17.61M | -18.65M | -13.79M | -9.26M | -9.31M | 0.23M | ||||||
| Interest ExpensesInt Expense | 0.01M | 0.00M | 0.02M | 0.01M |